Financial Instruments and Fair Value Measurements (Schedules of Concentration of Risk) (Details)	1 Months Ended	3 Months Ended			6 Months Ended
	Jul. 01, 2022	Jun. 30, 2023	Mar. 31, 2023	Jun. 16, 2022	Jun. 30, 2023	Jun. 16, 2022
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | CuraScript, Inc
Concentration Risk
Concentration Risk, Percentage						15.60%
Distributor Concentration Risk | Revenue from Contract with Customer Benchmark [Member] | FFF Enterprises, Inc.
Concentration Risk
Concentration Risk, Percentage	23.60%	23.80%		26.90%	21.40%	11.80%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | Amerisource Bergen Corporation [Member]
Concentration Risk
Concentration Risk, Percentage		24.50%	23.30%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | McKesson Corporation [Member]
Concentration Risk
Concentration Risk, Percentage		21.60%	17.30%
Distributor Concentration Risk | Accounts Receivable Attributable to Distributors | FFF Enterprises, Inc.
Concentration Risk
Concentration Risk, Percentage			16.20%
Product Concentration Risk | Net Sales Attributable to Products | Acthar
Concentration Risk
Concentration Risk, Percentage	32.40%	24.60%		24.60%	22.10%	25.40%
Product Concentration Risk | Net Sales Attributable to Products | Inomax
Concentration Risk
Concentration Risk, Percentage	15.80%	16.20%		17.40%	17.70%	19.00%
Product Concentration Risk | Net Sales Attributable to Products | Therakos [Member]
Concentration Risk
Concentration Risk, Percentage	12.00%	13.20%		13.00%	13.50%	12.50%
Product Concentration Risk | Net Sales Attributable to Products | APAP
Concentration Risk
Concentration Risk, Percentage	13.30%	12.60%		13.10%	11.80%	11.00%